Merck Animal Health To Present Important Data At The 28th World Buiatrics Congress In Cairns, Australia

Bovine Virus Diarrhea (BVD), Herd Health, Udder Health and Reproduction to be Discussed

Merck Animal Health (known as MSD Animal Health outside the USA and Canada) will present from 19 posters and 1 oral presentation at the 28th World Buiatrics Congress (WBC) in Cairns, Australia, from July 27 – August 1, 2014. WBC brings veterinarians and animal health professionals together to exchange ideas and receive the latest information and insights from international experts on buiatrics. The posters are mainly focused on Bovine Virus Diarrhea (BVD), Herd Health, Lung Health, Udder Health and Reproduction.

“Merck Animal Health’s leadership in the ruminants sector has a solid foundation with a strong commitment to the Science of Healthier Animals™,” said Fernando Heiderich, Merck Animal Health. “We are pleased to have the opportunity to present our data on ruminant health to industry leaders at WBC. We have the right products and the best people to offer a comprehensive set of
unique solutions to our customers.”

Abstracts selected for presentations are as follows:
Oral Presentation:
Inhibition of priming for bovine respiratory syncytial virus specific protective immune responses following parenteral vaccination of passively immune calves
Poster Presentations:
Bovine Virus Diarrhea (BVD):
The Prevalence and Impact of BVD Congenital Infection in Beef Calves (Poster #84,
Session 1)
Efficacy of an inactivated BVD vaccine against prolonged high infection pressure in a combined vaccination schedule with a live IBR vaccine under field conditions (Poster #183,
Session 1)
Mastitis:
Antimicrobial susceptibility of Streptococcus uberis isolated in bovine mastitis in France
(Poster #506, Session 2)
Treatment of mastitis: bactericidal speed of different antibiotics against field strains of Streptococcus uberis (Poster #319, Session 2)
Comparison of minimum inhibitory concentrations of cephalonium to zone diameters
(Poster #467, Session 1)
Herd Health:
Evaluation of the efficacy and performance of preweaned Holstein calves treated with either Resflor Gold or Baytril for bovine respiratory disease (Poster #85, Session 1)
Identification of risk factors for bovine respiratory disease on Dutch dairy farms (Poster #111, Session 1)
Prevalence of Bovine Respiratory Disease pathogens in veal calves in the Netherlands (Poster #112, Session 1)
Prevalence of respiratory pathogen agents in beef cattle on French farms by using the Polymerase Chain Reaction (PCR) method (Poster #504, Session 1)
Blood levels of immunoglobulins G and total proteins: follow up study on young dairy calves
(Poster #320, Session 1)
Small Ruminants:
Effects of the moment of insemination after removal of Chronogest® CR sponge on AI success in Corsican ewes (Poster #507, Session 1)
Lung Health & Welfare:
Clinical efficacy of a novel Flunixin Transdermal formulation for the control of pyrexia associated with naturally-occurring bovine respiratory disease: a multi-center field trial
(Poster #140, Session 2)
Effectiveness and safety of a novel flunixin meglumine transdermal pour-on solution in the treatment of bovine respiratory disease (Poster #382, Session 2)
Reproduction:
Validation of diagnostic methods for clinical and cytological endometritis in dairy cows (Poster #86, Session 2)
Resynchronization with unknown pregnancy status using progestin-based timed artificial insemination protocol in beef cattle (Poster #102, Session 2)
Productivity associated factors in French Charolais cow-calf operations monitored by Bovins Croissance Organization (Poster #505, Session 2)
Other Topics of Interest:
Effect of Flunixin on Leather Quality of Cattle treated with a Finadyne Transdermal solution (Poster #139, Session 2)
Comparison of Flunixin Plasma Levels Following A Single Dose Of Flunixin Transdermal Solution To Cattle Allowed Or Prevented From Licking In A Crossover Study (Poster #378,
Session 2)
Post-treatment dosing site assessment following topical administration of a novel formulation of flunixin transdermal solution: summary of seven studies (Poster #380,
Session 2)
Selected topics will be featured on the company’s Studio Bovine™, an online channel
dedicated to bovine health. Studio Bovine has been designed to meet customers’ need for
information in a convenient and engaging format. The channel is an ideal showcase for information
and industry leaders at the 28th World Buiatrics Congress.
For more information on the World Buiatrics Congress, please visit www.wbc2014.com.

About Studio Bovine™
An initiative of Merck Animal Health (known as MSD Animal Health outside the USA and
Canada), Studio Bovine is dedicated to broadcasting knowledge and farm intelligence in bovine
health and productivity. Through online video interviews with leading experts, Studio Bovine is
committed to examining complete solutions, equipping veterinarians and farmers with up-to-date
and actionable information on issues such as handling, preventive medicine, treatment strategies
and performance solutions. Studio Bovine is intended as a platform for interaction and exchange
within the global community of bovine professionals. The goal: a shared, integrated vision on
Bovine health, sustainability, productivity and quality. For more information and additional video
features, please visit www.studiobovine.com.

Sponsored Introduction Continue on to (or wait seconds) ×